Retrieve available abstracts of 29 articles: HTML format
Single Articles
June 2025
YUAN Q, Li X, Chen X, Xiao J, et al 7?Difluoromethoxyl?5,4'?di?n?octylygenistein targets the STAT3 pathway by
upregulating microRNA?152?3p expression to inhibit self?renewal and tumor growth
in non?small cell lung carcinoma.
Oncol Rep. 2025;53:66. PubMedAbstract available
May 2025
HU Y, Liu X, Yuan Z, He J, et al Induction of necroptosis in lung adenocarcinoma by miR?10b?5p through modulation
of the PKP3/RIPK3/MLKL cascade.
Oncol Rep. 2025;53:56. PubMedAbstract available
LIN GB, Chen WT, Kuo YY, Liu HH, et al Thermal cycling?hyperthermia sensitizes non?small cell lung cancer A549 cells to
EGFR tyrosine kinase inhibitor erlotinib.
Oncol Rep. 2025;53:58. PubMedAbstract available
ZHANG J, Qi S, Du Y, Dai H, et al Effect of quercetin on inhibiting gefitinib?activated non?small cell lung
cancer?induced cell pyroptosis in cardiomyocytes via modulating mitochondrial
autophagy mediated by the SHP2/ROS/AMPK/XBP?1/DJ?1 signaling pathway.
Oncol Rep. 2025;53:57. PubMedAbstract available
April 2025
ZHANG L, Wang S, Wang L Pan?cancer analysis of oncogene SFXN1 to identify its prognostic and
immunological roles in lung adenocarcinoma.
Oncol Rep. 2025;53:50. PubMedAbstract available
February 2025
PENG Y, Li D, Wampfler JA, Luo YH, et al Targeted therapy?associated cardiotoxicity in patients with stage?IV lung cancer
with or without cardiac comorbidities.
Oncol Rep. 2025;53:25. PubMedAbstract available
ZHOU S, Sun J, Zhu W, Yang Z, et al Hypoxia studies in non?small cell lung cancer: Pathogenesis and clinical
implications (Review).
Oncol Rep. 2025;53:29. PubMedAbstract available
January 2025
MUTO S, Homma MK, Kiko Y, Ozaki Y, et al Nucleolar casein kinase 2 alpha as a prognostic factor in patients with
surgically resected early?stage lung adenocarcinoma.
Oncol Rep. 2025;53:4. PubMedAbstract available
WANG M, Chen X, Fu G, Ge M, et al [Retracted] Glutathione peroxidase 2 overexpression promotes malignant
progression and cisplatin resistance of KRAS?mutated lung cancer cells.
Oncol Rep. 2025;53:1. PubMedAbstract available
December 2024
WEI Q, Lin J, Lin Z, Yu N, et al GOLPH3 inhibition overcomes cisplatin resistance by restoring the
glutathione/reactive oxygen species balance in the A549 non?small cell lung
cancer cell line.
Oncol Rep. 2024;52:170. PubMedAbstract available
HU X, Zhang S, Zhang X, Liu H, et al HOXD1 inhibits lung adenocarcinoma progression and is regulated by DNA
methylation.
Oncol Rep. 2024;52:173. PubMedAbstract available
November 2024
GUI H, Nie Y, Yuan H, Jing Q, et al The combination of a PTP1B inhibitor, TNFR2 blocker, and PD?1 antibody suppresses
the progression of non?small cell lung cancer tumors by enhancing
immunocompetence.
Oncol Rep. 2024;52:149. PubMedAbstract available
KANAYAMA M, Yoneda K, Kuwata T, Mori M, et al Enhanced capture system for mesenchymal?type circulating tumor cells using a
polymeric microfluidic device 'CTC?Chip' incorporating cell?surface vimentin.
Oncol Rep. 2024;52:156. PubMedAbstract available
GEORGAKOPOULOU VE, Lempesis IG, Trakas N, Sklapani P, et al Lung cancer and obesity: A contentious relationship (Review).
Oncol Rep. 2024;52:158. PubMedAbstract available
October 2024
ZHOU M, Wei L, Lu R Emerging role of sirtuins in non?small cell lung cancer (Review).
Oncol Rep. 2024;52:127. PubMedAbstract available
WEI W, Zhao X, Zhu J, Zhang L, et al [Retracted] lncRNA?u50535 promotes the progression of lung cancer by activating
CCL20/ERK signaling.
Oncol Rep. 2024;52:126. PubMedAbstract available
MUNKHJARGAL B, Kondo K, Soejima S, Tegshee B, et al DNA methylation and mRNA expression of ZNF577 as biomarkers for the detection and
prognosis of lung adenocarcinoma.
Oncol Rep. 2024;52:131. PubMedAbstract available
August 2024
LI S, Wang H, Ma R, Wang L, et al [Retracted] Schisandrin B inhibits epithelial?mesenchymal transition and stemness
of large?cell lung cancer cells and tumorigenesis in xenografts via inhibiting
the NF?kappaB and p38 MAPK signaling pathways.
Oncol Rep. 2024;52:102. PubMedAbstract available
July 2024
CHENG SH, Tu KY, Lee HH The dynamic duo: A narrative review on the synergy between stereotactic body
radiotherapy and immunotherapy in lung cancer treatment (Review).
Oncol Rep. 2024;52:96. PubMedAbstract available
June 2024
GAO Y, Zhang G, Liu J, Li H, et al [Retracted] Tissue?specific transplantation antigen P35B functions as an oncogene
and is regulated by microRNA?125a?5p in lung cancer.
Oncol Rep. 2024;51:76. PubMedAbstract available
February 2024
ZHANG F, Qi Y, Li J, Liu B, et al Activin A induces apoptosis of human lung adenocarcinoma A549 cells through
endoplasmic reticulum stress pathway.
Oncol Rep. 2024;51:29. PubMedAbstract available
LU X, Ma S, Li Y, Pan Y, et al Identification of ITGB4 as a novel tumor promoting gene in lung adenocarcinoma
(LUAD).
Oncol Rep. 2024;51:30. PubMedAbstract available
LOU H, Wu Z, Wei G CDC6 may serve as an indicator of lung adenocarcinoma prognosis and progression
based on TCGA and GEO data mining and experimental analyses.
Oncol Rep. 2024;51:35. PubMedAbstract available
January 2024
CHENG Z, Cui H, Wang Y, Yang J, et al The advance of the third?generation EGFR?TKI in the treatment of non?small cell
lung cancer (Review).
Oncol Rep. 2024;51:16. PubMedAbstract available
December 2023
LIU J, Zhang F, Wang J, Wang Y, et al MicroRNA?mediated regulation in lung adenocarcinoma: Signaling pathways and
potential therapeutic implications (Review).
Oncol Rep. 2023;50:211. PubMedAbstract available
November 2023
CHEN Z, Li P, Shen L, Jiang X, et al Heat shock protein B7 (HSPB7) inhibits lung adenocarcinoma progression by
inhibiting glycolysis.
Oncol Rep. 2023;50:196. PubMedAbstract available
WU Z, Liu S, Pang G, Jiang H, et al RNA?binding protein quaking 5 inhibits the progression of non?small cell lung
cancer by upregulating netrin?4 expression.
Oncol Rep. 2023;50:204. PubMedAbstract available
TIAN C, Li J, Ren L, Peng R, et al [Retracted] MicroRNA?381 serves as a prognostic factor and inhibits migration and
invasion in non?small cell lung cancer by targeting LRH?1.
Oncol Rep. 2023;50:203. PubMedAbstract available
ZHANG J, Darman L, Hassan MS, Von Holzen U, et al Targeting KRAS for the potential treatment of pancreatic ductal adenocarcinoma:
Recent advancements provide hope (Review).
Oncol Rep. 2023;50:206. PubMedAbstract available